DocMorris AGXSWX:DOCM +1.84%65 Receivables Turnover is 10.32 as of Jun. 2025. GuruFocus rates XSWX:DOCM with a GF Score™ of 65/100 and a GF Value™ of CHF10.53 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 660 Healthcare Providers & Services companies, DocMorris AG ranks better than 83.79% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. DocMorris AG's Revenue for the
six
months ended in Jun. 2025 was CHF541 Mil. DocMorris AG's average Accounts Receivable for the
six
months ended in Jun. 2025 was CHF52 Mil.
Hence, DocMorris AG's Receivables Turnover for the
six
months ended in Jun. 2025 was 10.32.
DocMorris AG (XSWX:DOCM) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
DocMorris AG Receivables Turnover Related Terms
DocMorris AG Receivables Turnover Historical Data
* Premium members only.
The historical data trend for DocMorris AG's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DocMorris AG Receivables Turnover Competitor Comparison
For the Pharmaceutical Retailers subindustry, DocMorris AG's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DocMorris AG Receivables Turnover vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DocMorris AG's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where DocMorris AG's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DocMorris AG (XSWX:DOCM) has a Receivables Turnover of 10.32 as of Jun. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on DocMorris AG and its competitors. According to the industry distribution chart, DocMorris AG ranks #107 out of 660 companies in the Healthcare Providers & Services industry, placing it in the top 16.2%.
Is DocMorris AG's Receivables Turnover too high?
DocMorris AG's current Receivables Turnover is 10.32. The Healthcare Providers & Services industry median Receivables Turnover is 7.64. DocMorris AG's value of 10.32 is 35.1% above this industry median. Based on the distribution chart, DocMorris AG ranks #107 out of 660 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, DocMorris AG has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DocMorris AG's Receivables Turnover compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, DocMorris AG ranks #107 out of 660 companies for Receivables Turnover. This places DocMorris AG in the top 16% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 7.64. DocMorris AG's value of 10.32 is 35.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Healthcare Providers & Services company?
The median Receivables Turnover among Healthcare Providers & Services companies is 7.64, based on 660 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DocMorris AG's current Receivables Turnover of 10.32 is 35.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on DocMorris AG and its competitors. For the Healthcare Providers & Services industry, the median Receivables Turnover is 7.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DocMorris AG's current Receivables Turnover is 10.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DocMorris AG stock overvalued right now?
Based on GuruFocus' analysis, DocMorris AG (XSWX:DOCM) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF10.53, compared to a current price of CHF8.30 — trading 21.2% below its estimated fair value. The current Receivables Turnover is 10.32 and 35.1% above the Healthcare Providers & Services industry median of 7.64. DocMorris AG's overall GF Score™ is 65/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For DocMorris AG (XSWX:DOCM), the current Receivables Turnover is 10.32 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DocMorris AG (XSWX:DOCM) Overvalued in 2026?
Based on GuruFocus' analysis, DocMorris AG stock appears to be undervalued.
The current stock price of CHF8.30 is trading 21.2% below its estimated GF Value™ of CHF10.53.
GuruFocus considers DocMorris AG to be Modestly Undervalued.
Key valuation signals for XSWX:DOCM:
Receivables Turnover: 10.32
GF Value™: CHF10.53 vs. price of CHF8.30 (21.2% below fair value)
Industry Position: 35.1% above the Healthcare Providers & Services median (#107 of 660)
No single metric tells the full story. See the XSWX:DOCM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DocMorris AG is engaged in the fields of online pharmacy, marketplace, and professional healthcare with brands in Germany and other European countries. Its brands are DocMorris, PromoFarma by DocMorris, and TeleClinic. The Group's reportable segments are Germany and Europe. The Germany segment comprises the mail-order business in drugs and health products, as well as services for mail-order pharmacies. The Europe segment comprises the marketplace business of PromoFarma and Doctipharma. The majority of revenue is generated from Germany segment.
65GF Score
Get the complete analysis for XSWX:DOCM
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:DOCM has been successfully added to your 
